Novelix Pharmaceuticals: New Whole Time Director Appointed

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.3%Reaction day

₹70.00

prior close

₹70.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-3.3% vs market

Healthcare Services peers, median of 66sector · industry level-1.3%-2.0% vs sector

On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.0 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.3+0.0-3.3-1.3-2.0

Next day

-1.5+1.3-2.8-1.1-0.4

-2.9+1.1-3.9-1.0-1.8

-4.3-1.7-2.6-3.4-0.9

-2.2-1.4-0.7-2.0-0.1

-7.9-0.6-7.3-3.2-4.6

-6.4+0.3-6.7-3.6-2.8

15d

-14.2-6.1-8.1-6.2-8.1

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 66Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Novelix Pharmaceuticals shareholders at the 32nd AGM on 30 September 2026 approved the appointment of Mr. Gnana Prakash Gattu as Whole Time Director for 5 years, effective 29 August 2026. He is an IIT-Chennai graduate with over 25 years of experience in management and IT. He belongs to the promoter group and is not related to any existing directors or KMPs. He is not debarred by SEBI from holding office.

Likely market impact

Promoter-group director appointment signals leadership continuity; long 5-year term suggests stability. Minimal direct impact on stock price.